Clinical trial
N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery
NCT00188630 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188630 |
|---|---|
| Title | N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery |
| Official title | The PRIME (Perioperative Renal Insufficiency Management) Study: A Randomized, Double-blinded, Placebo-controlled Trial of N-acetylcysteine for Preventing Renal Injury After Cardiac Surgery. |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Heart and Stroke Foundation of Ontario |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Disease, Acute Renal Failure |
| Intervention type | Drug, Other |
| Interventions | N-acetylcysteine, 5% dextrose solution |
| Enrollment | 176 |
| Start date | Jul 1, 2003 |
| Primary completion | Feb 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 20, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: